Status:

NOT_YET_RECRUITING

Bioavailability of Micronutrients With a Special Focus on Vitamin K Dependent on Consumed Diet

Lead Sponsor:

University of Copenhagen

Collaborating Sponsors:

Technical University of Denmark

Conditions:

Micronutrient Status

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

Objectives The main objectives are: • Study part II: to investigate the effect of a plant-based diet on micronutrient status compared to an average Danish diet Hypotheses Study part II: it is hypot...

Detailed Description

Overall study design Study part II (n= 16 completers): A 4-week randomised parallel intervention trial comparing status of some micronutrients (with main focus on MK-9 and ferritin) after consumption ...

Eligibility Criteria

Inclusion

  • Men and women
  • Between 18 and 65 years old (including both 18 and 65 year olds)
  • Danish-speaking
  • Willingness to consume/comply with consumption of study-related intervention products/diet
  • Willing to take 10 µg vitamin D3/day and omit intake of all other (vitamins and mineral) supplements before and during the trial
  • BMI ≤ 30.0 kg/m2
  • Habitual consumption of meat at dinner minimum 5 times per week. Meat is defined as red meat and poultry, where red meat is consumed at dinner at least 2 out of 5 times per week (fish consumption is not included in the "5 per week" meat definition).

Exclusion

  • Daily smokers/users of all kinds of nicotine-containing products.
  • Occasional smokers/user can be included if they are willing to refrain from all kinds of nicotine-containing products during the trial (from screening to end of trial)
  • Blood donation \<3 months prior to study-related blood sampling
  • Intensive physical training (\> 10 hours of strenuous physical activity per week)
  • Participation in other clinical studies at the time of the study
  • Pregnant, lactating or planning to become pregnant within the study period
  • Habitual alcohol intake above current recommendation (\> 10 alcoholic units/week)
  • History of cancer within the past five (5) years except basal cell skin cancer and cervix
  • Diagnosed with chronic inflammation disorders
  • Diagnosed with gastrointestinal diseases
  • Diagnosed with bone related diseases
  • Diagnosed with psychiatric disorder including depression that requires medical treatment
  • Medical treatment of diabetes
  • Medical treatment of cardiovascular related disease
  • Surgical change of the gastrointestinal tract (removal of appendix is allowed)
  • Use of prescription medication that can affect their safety or impact on data
  • Inability, physically or mental, to comply with the procedure required by the study protocol and evaluated by the principal investigator (PI), study manager or clinical responsible

Key Trial Info

Start Date :

April 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 30 2031

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT06921018

Start Date

April 1 2025

End Date

June 30 2031

Last Update

April 10 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Copenhagen

Frederiksberg, Denmark, 1958